Gainers
- Palisade Bio PALI shares rose 104.3% to $2.86 during Thursday's pre-market session. The company's market cap stands at $4.3 million.
- Trevi Therapeutics TRVI stock rose 57.02% to $3.91. The market value of their outstanding shares is at $300.5 million.
- Conduit Pharmaceuticals CDT stock rose 21.97% to $0.11. The company's market cap stands at $12.5 million.
- Gossamer Bio GOSS stock moved upwards by 17.16% to $0.83. The market value of their outstanding shares is at $189.1 million.
- Jupiter Neurosciences JUNS shares increased by 16.52% to $13.4. The company's market cap stands at $440.5 million.
- Aptevo Therapeutics APVO shares moved upwards by 15.5% to $11.56. The market value of their outstanding shares is at $5.7 million.
Losers
- Keros Therapeutics KROS shares fell 72.9% to $18.6 during Thursday's pre-market session. The market value of their outstanding shares is at $753.4 million.
- Avinger AVGR stock decreased by 46.35% to $0.44. The company's market cap stands at $1.4 million.
- TFF Pharmaceuticals TFFP stock declined by 45.98% to $0.09.
- SHL Telemedicine SHLT shares declined by 21.35% to $2.69. The company's market cap stands at $44.0 million.
- Telix Pharmaceuticals TLX shares declined by 17.57% to $13.0. The company's market cap stands at $4.3 billion.
- Evaxion Biotech EVAX stock fell 10.77% to $1.16. The market value of their outstanding shares is at $6.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AVGRAvinger Inc
$0.5950-29.2%
CDTConduit Pharmaceuticals Inc
$0.0827-6.34%
EVAXEvaxion Biotech AS
$1.24-5.00%
GOSSGossamer Bio Inc
$0.913628.2%
JUNSJupiter Neurosciences Inc
$15.5535.2%
KROSKeros Therapeutics Inc
$18.58-72.9%
PALIPalisade Bio Inc
$2.3668.6%
SHLTSHL Telemedicine Ltd
$2.99-12.4%
TFFPTFF Pharmaceuticals Inc
$0.0640-60.7%
TLXTelix Pharmaceuticals Ltd
$15.680.53%
TRVITrevi Therapeutics Inc
$3.5944.1%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in